Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Atherogenics Inc. (AGIX)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on AGIX
Newest on AGIX
Alan Brochstein
(1)
John Cramer
(1)
Maxim Jacobs
(1)
Anthony Payne
(1)
Andrew Vaino
(1)
Most frequent on AGIX
TickerSense
(
4
)
SA Editor Miriam Metzinger
(
3
)
Centient Biotech Investor
(
3
)
John Cramer
(
1
)
Maxim Jacobs
(
1
)
Most followed on AGIX
SA Editor Eli Hoffmann
(
614
)
Alan Brochstein
(
540
)
SA Editor Miriam Metzinger
(
301
)
SA Editors
(
123
)
TickerSense
(
116
)
Most commented on AGIX
TickerSense
(
2
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Atherogenics Inc. (AGIX)
by
latest
|
most commented
The Best and Worst Performing Stocks in the U.S.
Apr 24, 2008
•
TickerSense
•
AMPX
,
AGIX
,
ABK
•
2 Comments
|
Quick Read
The Next Great Biotech Short Squeeze
Apr 23, 2007
•
Andrew Vaino
•
AGIX
,
AVNR
,
BLUS
•
Comment!
|
Quick Read
AstraZeneca Terminates Production of AtheroGenics' AGI-1067; Beats Pretax Estimates
Apr 23, 2007
•
SA Editor Jonathan Liss
•
AGIX
,
AZN
•
Comment!
|
Quick Read
Russell 3000's Best and Worst Stocks, Week and Year to Date
Apr 14, 2007
•
TickerSense
•
ADLR
,
AGIX
,
DNDN
•
Comment!
|
Quick Read
Russell 3000's Best and Worst Stocks, Week and Year to Date
Apr 8, 2007
•
TickerSense
•
CEGE
,
DF
,
AGIX
•
Comment!
|
Quick Read
How To Avoid Investment Landmines
Apr 2, 2007
•
Alan Brochstein
•
AGIX
,
BFT
,
CBAK
•
Comment!
|
Quick Read
AtheroGenics' Heart Drug Shows Promise on Secondary Goals
Mar 28, 2007
•
SA Editor Judith Levy
•
AGIX
,
AZN
•
Comment!
|
Quick Read
Biotech Day In Review: Regeneron Up On AMD Data
Mar 28, 2007
•
AGIX
,
ARXT
,
BCRX
•
Comment!
|
Quick Read
Russell 3000's Best and Worst Stocks, Week and Year to Date
Mar 24, 2007
•
TickerSense
•
FSLR
,
AGIX
,
ACAD
•
Comment!
|
Quick Read
Biotech Day in Review: AtheroGenics Tumbles on Drug Test Failure
Mar 20, 2007
•
Centient Biotech Investor
•
AGIX
,
ALXN
,
ACAD
•
Comment!
|
Quick Read
AtheroGenics' Heart Drug Misses Primary Endpoint, Shares Plummet
Mar 19, 2007
•
SA Editor Eli Hoffmann
•
AGIX
•
Comment!
|
Quick Read
AtheroGenics: No Guts, No Glory
Feb 8, 2007
•
John Cramer
•
AGIX
•
Comment!
|
Quick Read
The Short Case On Atherogenics
Feb 1, 2007
•
Maxim Jacobs
•
AGIX
•
Comment!
|
Quick Read
AtheroGenics: The Clock Is Ticking
Jan 30, 2007
•
Anthony Payne
•
AGIX
•
Comment!
|
Quick Read
Biotech Stocks Review: Amphora Sells Oncology Program to Genentech
Jan 10, 2007
•
Centient Biotech Investor
•
BIIB
,
AGIX
,
ALNY
•
Comment!
|
Quick Read
Alnylam, CytRx Gain by Moving into RNAi
Jan 10, 2007
•
H.S. Ayoub
•
AGIX
,
ALNY
,
CYTR
•
Comment!
|
Quick Read
Biotech Stocks Day-in-Review: Controversy For Genentech Cancer Drug
Jan 7, 2007
•
Centient Biotech Investor
•
DNA
,
AGIX
,
BMRN
•
Comment!
|
Quick Read
Pharma IPO: Highlights from ActivBiotics' S-1 Filing
Aug 23, 2006
•
Evelyn Rubin
•
AGIX
,
DCGN
,
ACTV
•
Comment!
|
Quick Read
One Page Barron's Summary
May 15, 2006
•
SA Editors
•
AGIX
,
BID
,
CHRW
•
Comment!
|
Quick Read